MitraClip® procedure as bridge to left ventricular assist device: Enable extracorporeal membrane oxygenation weaning and reduce perioperative risk. (April 2023)

• Record Type: Journal Article
• Authors: Schmiady, Martin O.; Winnik, Stephan; Bettex, Dominique; Aser, Raed
• Is Part Of: Perfusion. Volume 38:Number 3(2023)
• Page Start: 651
• Page End: 653
• Publication Date: 2023-04
• Subjects: MitraClip®, extracorporeal membrane oxygenation -- left ventricular assist device -- Impella® microaxial blood pump -- mitral regurgitation, end-stage heart failure -- cardiac shock; Perfusion (Physiology) -- Periodicals; Blood -- Circulation, Artificial -- Periodicals; Heart -- Surgery -- Periodicals; Extracorporeal Circulation -- Periodicals; Perfusion -- Periodicals; Circulation extracorporelle -- Périodiques; Perfusion -- Périodiques; 617.41
• DOI: 10.1177/02676591211065251
• Languages: English
• ISSNs: 0267-6591

Abstract

Secondary mitral valve regurgitation is a frequent consequence of left ventricular dysfunction in patients with severe heart failure. The management of this disease can be challenging since it often culminates in refractory pulmonary edema and multi-organ failure. We present the case of a 50-year-old male who was admitted in cardiogenic shock following myocardial infarction. After successful revascularization, percutaneous mitral valve repair using the MitraClip ® device enabled weaning from extracorporeal membrane oxygenation followed by the implantation of a left ventricular assist device as bridge to transplant.